[The significance of laboratory findings in long-term antiepileptic therapy]. 1991

A Doppelbauer, and J Zeitlhofer, and S Obergottsberger, and C Baumgartner, and C Lind, and N Mayr, and L Deecke
Neurologische Universitätsklinik, Wien.

A retrospective study of 316 patients (173 men, 143 women; mean age 39 [17-87] years) who had taken antiepileptics (phenytoin, phenobarbital, carbamazepine, valproic acid) for at least six months, was carried out to assess the biochemical and haematological changes in relation to the drug used, the therapeutic programme and the drug serum levels. The most frequent change was isolated elevation of gamma-GT (9-89% of cases depending on the drug), followed by elevation of alkaline phosphatase (16-44%). Increases in the transaminases GOT (4-13%) and GPT (4-19%) were infrequent and minor. Changes in the blood picture were very infrequent and never more than minimal. Correlation between all these changes and serum drug levels was poor (r less than 0.15). Correlations between drug serum level and dose were found in the case of phenobarbital (r = 0.6) and valproic acid (r = 0.5). There was hence no evidence of any clear connection between the biochemical findings and the serum concentrations of antiepileptic drugs or their-dosage. The results indicate that undue importance has previously been attached to routine checks of biochemical parameters; abnormal biochemical findings by themselves are not usually enough to necessitate changes in treatment. Determination of biochemical and haematological parameters is necessary only if there are clinical grounds for it such as suspicion of side effects, the occurrence of epileptic attacks despite therapy, or change from one drug to another.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D001769 Blood The body fluid that circulates in the vascular system (BLOOD VESSELS). Whole blood includes PLASMA and BLOOD CELLS.
D001773 Blood Cells The cells found in the body fluid circulating throughout the CARDIOVASCULAR SYSTEM. Blood Corpuscles,Blood Cell,Blood Corpuscle,Cell, Blood,Cells, Blood,Corpuscle, Blood,Corpuscles, Blood
D001774 Blood Chemical Analysis An examination of chemicals in the blood. Analysis, Blood Chemical,Chemical Analysis, Blood,Analyses, Blood Chemical,Blood Chemical Analyses,Chemical Analyses, Blood
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D004359 Drug Therapy, Combination Therapy with two or more separate preparations given for a combined effect. Combination Chemotherapy,Polychemotherapy,Chemotherapy, Combination,Combination Drug Therapy,Drug Polytherapy,Therapy, Combination Drug,Chemotherapies, Combination,Combination Chemotherapies,Combination Drug Therapies,Drug Polytherapies,Drug Therapies, Combination,Polychemotherapies,Polytherapies, Drug,Polytherapy, Drug,Therapies, Combination Drug
D004827 Epilepsy A disorder characterized by recurrent episodes of paroxysmal brain dysfunction due to a sudden, disorderly, and excessive neuronal discharge. Epilepsy classification systems are generally based upon: (1) clinical features of the seizure episodes (e.g., motor seizure), (2) etiology (e.g., post-traumatic), (3) anatomic site of seizure origin (e.g., frontal lobe seizure), (4) tendency to spread to other structures in the brain, and (5) temporal patterns (e.g., nocturnal epilepsy). (From Adams et al., Principles of Neurology, 6th ed, p313) Aura,Awakening Epilepsy,Seizure Disorder,Epilepsy, Cryptogenic,Auras,Cryptogenic Epilepsies,Cryptogenic Epilepsy,Epilepsies,Epilepsies, Cryptogenic,Epilepsy, Awakening,Seizure Disorders
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

A Doppelbauer, and J Zeitlhofer, and S Obergottsberger, and C Baumgartner, and C Lind, and N Mayr, and L Deecke
January 1996, The Journal of emergency medicine,
A Doppelbauer, and J Zeitlhofer, and S Obergottsberger, and C Baumgartner, and C Lind, and N Mayr, and L Deecke
October 1978, Deutsche medizinische Wochenschrift (1946),
A Doppelbauer, and J Zeitlhofer, and S Obergottsberger, and C Baumgartner, and C Lind, and N Mayr, and L Deecke
June 1968, Monatsschrift fur Kinderheilkunde,
A Doppelbauer, and J Zeitlhofer, and S Obergottsberger, and C Baumgartner, and C Lind, and N Mayr, and L Deecke
July 1976, MMW, Munchener medizinische Wochenschrift,
A Doppelbauer, and J Zeitlhofer, and S Obergottsberger, and C Baumgartner, and C Lind, and N Mayr, and L Deecke
February 1972, Der Nervenarzt,
A Doppelbauer, and J Zeitlhofer, and S Obergottsberger, and C Baumgartner, and C Lind, and N Mayr, and L Deecke
June 1995, Pharmacology & toxicology,
A Doppelbauer, and J Zeitlhofer, and S Obergottsberger, and C Baumgartner, and C Lind, and N Mayr, and L Deecke
January 2013, Srpski arhiv za celokupno lekarstvo,
A Doppelbauer, and J Zeitlhofer, and S Obergottsberger, and C Baumgartner, and C Lind, and N Mayr, and L Deecke
May 1978, Beitrage zur Orthopadie und Traumatologie,
A Doppelbauer, and J Zeitlhofer, and S Obergottsberger, and C Baumgartner, and C Lind, and N Mayr, and L Deecke
June 2009, Epilepsia,
A Doppelbauer, and J Zeitlhofer, and S Obergottsberger, and C Baumgartner, and C Lind, and N Mayr, and L Deecke
July 1969, The American journal of medical technology,
Copied contents to your clipboard!